News
MIMOSA™ by TaraCares exits beta, as start-up gears up for expansion
The platform will allow women to integrate their health data with intelligence from academic research and clinical excellence

MIMOSA™, a first-of-its-kind virtual precision health platform developed by TaraCares Global, has exited its beta phase, as the start-up prepares for launch in 11 international markets.
MIMOSA™ aims to reimagine how female individuals of all ages, ethnicities and genders enter their unique menopause journey.
Empowered with menopause health literacy individualised to the user’s flavour of the menopause transition and accompanying life circumstances, the platform will provide women with a longitudinal Menopause Health Graph™ and Menopause Health Risk Profile™ that integrates their health data with intelligence from academic research and clinical excellence.
A B2B HealthTech SaaS platform, MIMOSA™ is currently available through employers. It has received glowing feedback from clinicians and individual users during the private launch that witnessed a user engagement rate of 84.38 per cent in 11 countries, including the four UK nations.

MIMOSA™ by TaraCares aims to educate and empower women throughout all the stages of the menopause
Dr/Prof. Vikram Sinai Talaulikar, a reproductive specialist at UCLH who has worked closely with TaraCares as a clinical advisor during the design and development of MIMOSA™ said: “The platform is easy to use, lovely images and colours, simple non-technical language so anyone can use it.

Dr Vikram Talaulikar, MD, FRCOG, PhD
“Out of comparable apps I have seen, MIMOSA™ stands out as comprehensive, inclusive, and easy-to-use,” Vikram, a certified menopause specialist by the British Menopause Society (BMS) and honorary associate professor at UCL, also added.
A user involved in the Innovate UK funded research study led by TaraCares said: “The ‘trace your health’ feature is so easy to use. It has certainly helped me understand the symptoms I could be experiencing while staying focussed on my self-care and nutritional needs. Journaling my thoughts felt so reassuring and calming.”
Business impact
TaraCares is currently in discussions with several public and private organisations including FTSE100 companies in the UK for trial pilots of MIMOSA™.
Last week, its founder and CEO, Jyoti Sharma, who has Indian origins and still reads Sanskrit, the ancient classical language of India in her spare time, announced the value-set that guides the decisions at TaraCares, adding “Be KRiiYa = Be Kind, Be Resilient, Be Intentional, Be Inspirational, Be You, Be Accountable.”
The company has been successful in signing established menopause corporate advisors and consultants as strategic alliances for their initial market penetration strategy, including Kirsty Dixon and Sally Duffin who have been appointed as strategic collaborators and members of the care team.
Describing herself as a postmenopausal woman with 12 years perimenopause experience under her belt, Dixon says her personal journey is her driving force to raise awareness and educate individuals and employers to ensure people receive research-based information and have access to the support they need to thrive.

Kirsty Dixon, strategic collaborator and member of the care team at TaraCares Global
Following on from her work at the University of York, where she changed the culture around menopause through awareness raising and setting up support initiatives, she set up Pause for Thought Consultancy in 2022, to help employers to do the same.
“I love everything about TaraCares. MIMOSA™ is easy to use and everything is research focused so any information is up-to-date and above all correct,” Dixon said.
“I class myself as a menopause educator so look forward to working with TaraCares. Also to be a critical friend and work alongside them to provide the best service for all who need menopause education and support.”
Duffin, another strategic collaborator, is a qualified registered nutritionist/nutritional therapist. She founded Nutrition in York to support support clients with digestive wellbeing, mental health, stress management, and hormonal issues.

Sally Duffin, strategic collaborator and member of the care team at TaraCares Global
After a short break from clinical work to write her book Natural Nutrition for Perimenopause – What to Eat to Feel Good and Stay Sane, she returned to private nutrition practice to focus on menopause support.
Duffin is a firm believer in the power of small steps that build healthy habits, understands the challenges clients face when trying to eat well and this is what excites her to be part of the team at TaraCares.
“TaraCares is built on a strong ethical foundation and has such a clear vision of what menopause care can and should look like. It’s exciting to be part of the team,” she said.
“We aim to support the whole menopause experience and provide accessible knowledge that users need to make informed, holistic decisions about their menopause transition.”
With MIMOSA™ expected to launch this summer, Sharma has revealed that several companies her team has been speaking to are already using solutions from competitors in the menopause space that have failed to deliver on the evidence base and benefits of the business case, highlighting the need for change and innovation.
The MIMOSA™ platform will be available for both Android and iOS. To find out more, email Jyoti Sharma at [email protected].

Pregnancy
Pregnant women may reduce key health risk through more light exercise, study finds

Light exercise and less sitting may reduce pregnant women’s risk of serious blood pressure complications, according to a new study.
Researchers have proposed a daily activity and sleep guide that they say was linked to a nearly 30 per cent lower risk of hypertensive disorders of pregnancy.
The suggested pattern includes fewer than eight hours of sedentary time, at least seven hours of light physical activity, around 22 minutes of more intense activity and nearly nine hours of sleep.
The University of Iowa-led study examined the daily behaviours of 470 pregnant women across all stages of pregnancy.
Participants wore monitors that measured physical activity over 24-hour periods and recorded how long they spent asleep.
Hypertensive disorders of pregnancy include chronic high blood pressure, gestational hypertension and pre-eclampsia.
Gestational hypertension is high blood pressure that develops during pregnancy, while pre-eclampsia is a potentially serious condition involving high blood pressure and signs that organs may be affected.
Sedentary behaviour means being mostly inactive, such as sitting or lying down.
Light physical activity can include casual walking, moving around the home or standing.
Moderate to vigorous activity includes movement such as brisk walking, where breathing and heart rate increase.
Kara Whitaker, associate professor in the department of health, sport, and human physiology at Iowa and corresponding author of the study, said: “We are identifying the optimal composition of movement behaviours across the day associated with the lowest risk of developing HDP and the most improved health outcomes.
“This blueprint holds for each and every trimester of pregnancy.”
Study participants were enrolled at sites in Iowa City, Pittsburgh and Morgantown, West Virginia.
The women wore activity and sleep monitors for at least one week during each trimester of pregnancy.
Four in five participants were non-Hispanic white and nearly a quarter lived in rural areas.
The data showed a steep rise in risk among pregnant women who were sedentary for more than 10 hours a day.
Women who increased light physical activity to at least four hours a day reduced their risk of hypertensive disorders of pregnancy to 15 per cent from 30 per cent.
Whitaker said: “Just moving around more seems to have significant health benefits.
“And I think it also may be a more feasible target for women who are pregnant who are not exercising regularly.”
The researchers said they were surprised that longer durations of moderate to vigorous physical activity did not appear to provide additional benefit.
Sleep beyond a certain duration also did not appear to bring major further benefits.
Whitaker said: “Through this study, we are providing evidence that reducing sedentary behaviour and engaging in light physical activity are important, and maybe more important, when it comes to pregnancy and health.”
The findings may be relevant beyond pregnancy because clinical research has shown that women who develop hypertensive disorders of pregnancy are more than twice as likely to develop heart disease later in life.
Cardiovascular disease includes conditions affecting the heart and blood vessels, such as heart disease and stroke.
Whitaker said: “We know that cardiovascular disease is the number one killer of women, and if we can intervene in pregnancy and prevent women from developing a hypertensive disorder of pregnancy, we are putting them on a better trajectory, away from cardiovascular disease and toward more optimal cardiovascular health.”
The study was published online on June 10.
A second study, published online on May 27, looked more closely at the ratio and type of sedentary behaviour and light physical activity linked to a lower risk of hypertensive disorders of pregnancy.
Whitaker is a lead co-author on that study.
Co-authors in the June 10 study include Alex Crisp, Jaemyung Kim, Karina Smith, Donna Santillan, Mark Santillan and Bridget Zimmerman, from Iowa; Jacob Gallagher, from Iowa State University; Melissa Jones, from Oakland University in Michigan; Bethany Barone Gibbs, Katrina Wilhite, Alexis Thrower and Iqra Sheikh, from West Virginia University; and Sabera Rahman, Janet Catov, Christopher Kline and Maisa Feghali, from the University of Pittsburgh.
The National Institutes of Health, the University of Iowa Institute for Clinical and Translational Science, the University of Pittsburgh Clinical and Translational Science Institute and the West Virginia Clinical and Translational Science Institute funded the research.
News
Femtech World Awards 2026: Winners revealed

We are excited to reveal the winners of the third annual Femtech World Awards.
The winners were announced at a virtual event this afternoon attended by shortlisted companies, along with sponsors and judges.
The event welcomed guests from the UK, Europe, Asia, Africa and North America.
Thank you to all 174 entries, as well as the sponsors for making the event possible.
See you in 2027!
Femtech World Awards 2026 Winners

Winner:
Shortlisted:
IVI RMA x Juno Genetics
Natural Cycles

Winner:
Highly commended:
U-Ploid
Shortlisted:
Hello Inside

Winner:
WISE HF, led by Prof. Mary Ryder
Highly commended:
Cardiac College for Women
Shortlisted:
Hyvelle Ferguson-Davis
CognitiveCare

Winner:
Highly commended:
Youterus
Shortlisted:
ŌURA

Winner:
Shortlisted:
LeanShield by ParrotPal Group
Perigen

Winner:
Shortlisted:
Body Moody
Looop

Winner:
Shortlisted:
Owning Your Menopause
Womeno

Winner:
Shortlisted:
The Blue Box
Celbrea

Winner:
Shortlisted:
HealCycle
Mor

Winner:
Shortlisted:
HRC Fertility
Mira
Motherhood
Expectations about sleep affect postpartum sleep quality, study finds

Pregnant women’s expectations about postpartum sleep may predict sleep quality after birth, outweighing prior sleep and psychiatric history, a study suggests.
The findings suggest attitudes and beliefs about sleep during pregnancy could be a modifiable risk factor for postpartum sleep concerns.
They also indicate that, among women expecting the poorest sleep, higher postpartum anxiety may further worsen sleep quality.
Sammy Dhaliwal, lead author is clinical health psychologist and research fellow in the department of obstetrics and gynaecology at the Perelman School of Medicine at the University of Pennsylvania.
Dhaliwal said: “Most pregnant women in our sample anticipated poor postpartum sleep before it occurred, and it was striking that those expectations predicted worse sleep outcomes even after accounting for factors such as prior sleep disorders, psychiatric history, and number of previous births.
“This suggests that attitudes and beliefs about sleep during pregnancy may represent a modifiable target for early intervention before postpartum sleep problems emerge.”
Sleep disturbance affects an estimated 60 to 80 per cent of postpartum women and is linked to a higher risk of depression and anxiety.
Researchers said it is often regarded as an expected part of life after childbirth rather than a health issue that may be addressed earlier.
The study enrolled 432 pregnant women at about 24 weeks of gestation, meaning around 24 weeks into pregnancy.
Participants completed measures of their expectations about postpartum sleep, current sleep quality using the Pittsburgh Sleep Quality Index, and mood using validated depression and anxiety scales.
Assessments were repeated at six, 12 and 24 weeks postpartum.
A subset of 49 women also wore wrist actigraphy devices at six to eight weeks postpartum.
Actigraphy uses a wearable device, similar to a watch, to estimate sleep and wake patterns based on movement.
The results showed that 70 per cent of pregnant women, or 301 of 432 participants, expected poor sleep in the postpartum period.
Researchers found that predicted sleep disruption during pregnancy was a significant predictor of postpartum sleep concerns.
Among first-time pregnant women without prior health concerns, those who expected greater sleep disturbance had significantly more disrupted sleep after birth, measured by both actigraphy and self-report.
Among women who expected the worst sleep quality, higher postpartum anxiety significantly worsened both measured sleep and self-reported sleep, independent of anxiety levels during pregnancy.
Dhaliwal said the findings point to two possible areas for intervention: addressing sleep-related beliefs during pregnancy and treating postpartum anxiety.
Dhaliwal said: “Postpartum sleep disruption is often treated only after problems develop, but our findings suggest there may be an opportunity to intervene earlier during pregnancy.
“Addressing sleep-related beliefs and postpartum anxiety during prenatal and postpartum care may help improve sleep and emotional well-being in new mothers.”
Menopause2 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health3 weeks agoNHS urged to update website following renaming of PCOS
News2 weeks agoWomen still being failed when they reach menopause, experts say
Entrepreneur2 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Insight1 week agoBritish women among angriest in Europe, health survey reveals
News2 weeks agoThree menopause innovators shortlisted for Femtech World Award
Fertility4 weeks agoAI could transform ovarian care through personalisation, study finds
News3 weeks agoLow insulin diet and avoiding four food groups may prevent menopause weight gain






















